Fumiko Kawasaki

1.5k total citations
63 papers, 1.1k citations indexed

About

Fumiko Kawasaki is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Fumiko Kawasaki has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Fumiko Kawasaki's work include Diabetes Treatment and Management (12 papers), Diabetes Management and Research (11 papers) and Diabetes and associated disorders (11 papers). Fumiko Kawasaki is often cited by papers focused on Diabetes Treatment and Management (12 papers), Diabetes Management and Research (11 papers) and Diabetes and associated disorders (11 papers). Fumiko Kawasaki collaborates with scholars based in Japan, United Kingdom and Australia. Fumiko Kawasaki's co-authors include Kohei Kaku, Kazuhiko Narita, Hiroshi Kita, Yukiko Kanda, Masafumi Matsuda, Michihiro Matsuki, Shankar Balasubramanian, Hiroshi Inoue, Isao Miyakawa and Hisashi Narahara and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Diabetes Care.

In The Last Decade

Fumiko Kawasaki

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumiko Kawasaki Japan 18 380 276 243 165 138 63 1.1k
Takeshi Endo Japan 15 711 1.9× 285 1.0× 126 0.5× 77 0.5× 152 1.1× 31 1.3k
Kaoru Suzuki Japan 21 415 1.1× 80 0.3× 191 0.8× 166 1.0× 130 0.9× 107 1.4k
Denise Zwanziger Germany 20 385 1.0× 316 1.1× 84 0.3× 73 0.4× 94 0.7× 62 1.1k
Anna Markowska Poland 22 927 2.4× 274 1.0× 125 0.5× 102 0.6× 197 1.4× 146 2.0k
Kenji Oki Japan 23 539 1.4× 570 2.1× 441 1.8× 110 0.7× 159 1.2× 67 1.4k
Lilia Magomedova Canada 16 314 0.8× 158 0.6× 167 0.7× 144 0.9× 141 1.0× 26 875
Phong Nguyen United States 23 539 1.4× 131 0.5× 69 0.3× 96 0.6× 200 1.4× 51 1.2k
Boxu Ren China 19 550 1.4× 80 0.3× 73 0.3× 147 0.9× 88 0.6× 33 1.3k
Ryoji Yamada Japan 16 805 2.1× 60 0.2× 102 0.4× 137 0.8× 112 0.8× 60 1.5k

Countries citing papers authored by Fumiko Kawasaki

Since Specialization
Citations

This map shows the geographic impact of Fumiko Kawasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiko Kawasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiko Kawasaki more than expected).

Fields of papers citing papers by Fumiko Kawasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiko Kawasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiko Kawasaki. The network helps show where Fumiko Kawasaki may publish in the future.

Co-authorship network of co-authors of Fumiko Kawasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiko Kawasaki. A scholar is included among the top collaborators of Fumiko Kawasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiko Kawasaki. Fumiko Kawasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimoda, Masashi, Masahiro Iwamoto, Shuhei Nakanishi, et al.. (2024). Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study). Frontiers in Endocrinology. 15. 1412553–1412553.
2.
Kawasaki, Fumiko, Yuka Mori, Hiroyuki Aburatani, et al.. (2023). Computational Design of Synthetic Optical Barcodes in Microdroplets. Advanced Optical Materials. 12(12). 1 indexed citations
3.
4.
Anno, Takatoshi, et al.. (2022). Ectopic PTH-producing parathyroid cyst inside the thymus: a case report. BMC Endocrine Disorders. 22(1). 327–327.
5.
Nakanishi, Shuhei, Masashi Shimoda, Fuminori Tatsumi, et al.. (2021). Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study. Diabetes Therapy. 12(7). 1849–1860.
6.
Anno, Takatoshi, Takashi Urano, Fumiko Kawasaki, et al.. (2021). Primary Epstein–Barr virus infection shortly after primary Cytomegalovirus infection: a case report. Journal of Medical Case Reports. 15(1). 257–257.
7.
Anno, Takatoshi, Yukiko Kimura, Fumiko Kawasaki, et al.. (2021). Case Report: Emphysematous Cystitis and Pyelonephritis Induced by Uterine Prolapse in a Subject With Untreated Diabetes Mellitus. Frontiers in Medicine. 8. 658682–658682. 2 indexed citations
8.
Anno, Takatoshi, Fumiko Kawasaki, Yuichiro Iwamoto, et al.. (2020). Basedow’s disease with associated features of Hashimoto’s thyroiditis based on histopathological findings. BMC Endocrine Disorders. 20(1). 120–120. 1 indexed citations
9.
Anno, Takatoshi, et al.. (2018). A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report. Journal of Medical Case Reports. 12(1). 286–286. 4 indexed citations
10.
11.
Kawasaki, Fumiko, Pierre Murat, Zhe Li, Tobias Santner, & Shankar Balasubramanian. (2017). Synthesis and biophysical analysis of modified thymine-containing DNA oligonucleotides. Chemical Communications. 53(8). 1389–1392. 21 indexed citations
12.
Anno, Takatoshi, Fumiko Kawasaki, Masayuki Yamamoto, et al.. (2017). Non-clostridial gas gangrene in a patient with poorly controlled type 2 diabetes mellitus on hemodialysis. Acta Diabetologica. 55(1). 99–101. 2 indexed citations
13.
Shimoda, Masashi, Hideaki Kaneto, Hiroshi Yoshioka, et al.. (2015). Influence of atherosclerosis‐related risk factors on serum high‐sensitivity C‐reactive protein levels in patients with type 2 diabetes: Comparison of their influence in obese and non‐obese patients. Journal of Diabetes Investigation. 7(2). 197–205. 9 indexed citations
14.
Kanda, Yukiko, Masashi Shimoda, Kazuhito Tawaramoto, et al.. (2009). Molecular Analysis of db Gene-related Pancreatic .BETA. Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote. Endocrine Journal. 56(8). 997–1008. 10 indexed citations
15.
Kanda, Yukiko, Masashi Shimoda, Sumiko Hamamoto, et al.. (2009). Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist. American Journal of Physiology-Endocrinology and Metabolism. 298(2). E278–E286. 53 indexed citations
16.
Matsuda, Masafumi, Fumiko Kawasaki, Kazunori Yamada, et al.. (2004). Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabetic Medicine. 21(8). 881–888. 56 indexed citations
17.
Saito, Miyuki, Masato Eto, Makoto Shigeto, et al.. (2004). “Effect of apoüpoprotein E4 alíele on plasma LDLcholesterol response to diet therapy in type 2 diabetic patients”. Apunts Medicina de l Esport. 39(144). 41–42. 1 indexed citations
18.
Kaku, Kohei, Fumiko Kawasaki, Yukiko Kanda, & Masafumi Matsuda. (2003). Retained capacity of glucose-mediated insulin secretion in patients with type 2 diabetes mellitus inversely correlates with the duration of diabetes. Diabetes Research and Clinical Practice. 64(3). 221–223. 3 indexed citations
19.
Kawasaki, Fumiko, et al.. (2003). The clinical role of interleukin-6 and interleukin-6 soluble receptor in human follicular fluids. Clinical and Experimental Medicine. 3(1). 27–31. 42 indexed citations
20.
Eto, Masaaki, Mieko Saito, Fumiko Kawasaki, et al.. (2002). Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. American Journal of Kidney Diseases. 40(2). 243–251. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Endo Breakdown of academic impact, for papers by Kaoru Suzuki Breakdown of academic impact, for papers by Denise Zwanziger Breakdown of academic impact, for papers by Anna Markowska Breakdown of academic impact, for papers by Kenji Oki Breakdown of academic impact, for papers by Lilia Magomedova Breakdown of academic impact, for papers by Phong Nguyen Breakdown of academic impact, for papers by Boxu Ren Breakdown of academic impact, for papers by Ryoji Yamada
Rankless by CCL
2026